VIEMED HEALTHCARE, INC. Cost of Revenue
VIEMED HEALTHCARE, INC. (VMD) reported Cost of Revenue of $33.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $33.05M, a 25.54% increase year-over-year.
- VIEMED HEALTHCARE, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $32.59M, a 26.06% increase year-over-year.
- VIEMED HEALTHCARE, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $32.08M, a 30.63% increase year-over-year.
- VIEMED HEALTHCARE, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $30.57M, a 29.35% increase year-over-year.
- VIEMED HEALTHCARE, INC. cost of goods and services sold for fiscal 2025 was $114.82M, a 26.10% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. cost of goods and services sold for fiscal 2024 was $91.05M, a 29.66% increase from fiscal 2023.
- VIEMED HEALTHCARE, INC. cost of goods and services sold for fiscal 2023 was $70.22M, a 29.68% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. cost of goods and services sold for fiscal 2022 was $54.15M, a 24.05% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $33.05M 10-Q · filed 2026-08-03 | $65.64M 10-Q · filed 2026-08-03 | $97.71M derived: sum of 3 quarters · filed 2026-08-03 | $128.28M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $32.59M 10-Q · filed 2026-05-05 | $64.67M derived: sum of 2 quarters · filed 2026-05-05 | $95.23M derived: sum of 3 quarters · filed 2026-05-05 | $121.56M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $32.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $62.65M derived: sum of 2 quarters · filed 2026-03-04 | $88.97M derived: sum of 3 quarters · filed 2026-08-03 | $114.82M 10-K · filed 2026-03-04 |
| 2025-09-30 | $30.57M 10-Q · filed 2025-11-05 | $56.89M derived: sum of 2 quarters · filed 2026-08-03 | $82.74M 10-Q · filed 2025-11-05 | $107.30M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $26.32M 10-Q · filed 2026-08-03 | $52.17M 10-Q · filed 2026-08-03 | $76.73M derived: sum of 3 quarters · filed 2026-08-03 | $100.36M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $25.85M 10-Q · filed 2026-05-05 | $50.41M derived: sum of 2 quarters · filed 2026-05-05 | $74.04M derived: sum of 3 quarters · filed 2026-05-05 | $96.11M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $24.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $48.19M derived: sum of 2 quarters · filed 2026-03-04 | $70.26M derived: sum of 3 quarters · filed 2026-03-04 | $91.05M 10-K · filed 2026-03-04 |
| 2024-09-30 | $23.63M 10-Q · filed 2025-11-05 | $45.71M derived: sum of 2 quarters · filed 2025-11-05 | $66.50M 10-Q · filed 2025-11-05 | $85.13M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | $22.07M 10-Q · filed 2025-08-06 | $42.86M 10-Q · filed 2025-08-06 | $61.49M derived: sum of 3 quarters · filed 2026-03-04 | $80.33M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | $20.79M 10-Q · filed 2025-05-07 | $39.42M derived: sum of 2 quarters · filed 2026-03-04 | $58.26M derived: sum of 3 quarters · filed 2026-03-04 | $75.46M derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | $18.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $37.47M derived: sum of 2 quarters · filed 2026-03-04 | $54.67M derived: sum of 3 quarters · filed 2026-03-04 | $70.22M 10-K · filed 2026-03-04 |
| 2023-09-30 | $18.84M 10-Q · filed 2024-11-06 | $36.05M derived: sum of 2 quarters · filed 2024-11-06 | $51.60M 10-Q · filed 2024-11-06 | $66.21M derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-06-30 | $17.20M 10-Q · filed 2024-08-07 | $32.76M 10-Q · filed 2024-08-07 | $47.37M derived: sum of 3 quarters · filed 2025-03-10 | $61.48M derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-03-31 | $15.55M 10-Q · filed 2024-05-06 | $30.16M derived: sum of 2 quarters · filed 2025-03-10 | $44.27M derived: sum of 3 quarters · filed 2025-03-10 | $57.19M derived: sum of 4 quarters · filed 2025-03-10 |
| 2022-12-31 | $14.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $28.72M derived: sum of 2 quarters · filed 2025-03-10 | $41.64M derived: sum of 3 quarters · filed 2025-03-10 | $54.15M 10-K · filed 2025-03-10 |
| 2022-09-30 | $14.11M 10-Q · filed 2023-11-01 | $27.03M derived: sum of 2 quarters · filed 2023-11-01 | $39.54M 10-Q · filed 2023-11-01 | $51.84M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $12.92M 10-Q · filed 2023-08-09 | $25.43M 10-Q · filed 2023-08-09 | $37.73M derived: sum of 3 quarters · filed 2023-08-09 | $48.64M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $12.51M 10-Q · filed 2023-05-08 | $24.81M derived: sum of 2 quarters · filed 2023-05-08 | $35.72M derived: sum of 3 quarters · filed 2023-05-08 | $45.49M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $12.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $23.20M derived: sum of 2 quarters · filed 2023-03-02 | $32.98M derived: sum of 3 quarters · filed 2023-03-02 | $43.65M 10-K · filed 2023-03-02 |
| 2021-09-30 | $10.90M 10-Q · filed 2022-11-01 | $20.68M derived: sum of 2 quarters · filed 2022-11-01 | $31.35M 10-Q · filed 2022-11-01 | $43.38M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $9.77M 10-Q · filed 2022-08-02 | $20.45M 10-Q · filed 2022-08-02 | $32.47M derived: sum of 3 quarters · filed 2022-08-02 | $46.47M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $10.67M 10-Q · filed 2022-05-03 | $22.70M derived: sum of 2 quarters · filed 2022-05-03 | $36.69M derived: sum of 3 quarters · filed 2022-05-03 | $53.62M derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $12.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $26.02M derived: sum of 2 quarters · filed 2022-03-07 | $42.95M derived: sum of 3 quarters · filed 2022-03-07 | $51.20M 10-K · filed 2022-03-07 |
| 2020-09-30 | $13.99M 10-Q · filed 2021-11-02 | $30.92M derived: sum of 2 quarters · filed 2021-11-02 | $39.17M 10-Q · filed 2021-11-02 | $46.38M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $16.93M 10-Q · filed 2021-08-03 | $25.18M 10-Q · filed 2021-08-03 | $32.38M derived: sum of 3 quarters · filed 2021-08-03 | $38.70M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $8.25M 10-Q · filed 2021-05-03 | $15.46M derived: sum of 2 quarters · filed 2021-05-03 | $21.78M derived: sum of 3 quarters · filed 2021-05-03 | $27.46M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $7.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $13.52M derived: sum of 2 quarters · filed 2021-03-03 | $19.21M derived: sum of 3 quarters · filed 2021-03-03 | $24.25M 10-K · filed 2021-03-03 |
| 2019-09-30 | $6.32M 10-Q · filed 2020-11-04 | $12.00M derived: sum of 2 quarters · filed 2020-11-04 | $17.05M 10-Q · filed 2020-11-04 | $21.89M derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | $5.69M 10-Q · filed 2020-08-04 | $10.73M 10-Q · filed 2020-08-04 | $15.57M derived: sum of 3 quarters · filed 2020-08-04 | $19.67M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $5.04M 10-Q · filed 2020-05-05 | $9.88M derived: sum of 2 quarters · filed 2020-05-05 | $13.99M derived: sum of 3 quarters · filed 2020-05-05 | $18.17M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $4.84M 10-K · filed 2020-03-04 | $8.95M derived: sum of 2 quarters · filed 2020-03-04 | $13.13M derived: sum of 3 quarters · filed 2020-03-04 | $16.69M 10-K · filed 2020-03-04 |
| 2018-09-30 | $4.10M 10-K · filed 2020-03-04 | $8.29M derived: sum of 2 quarters · filed 2020-03-04 | $11.85M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $4.18M 10-K · filed 2020-03-04 | $7.74M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $3.56M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |